Harris Associates’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,401,656
Closed -$144M 167
2025
Q4
$144M Sell
3,401,656
-35,841
-1% -$1.46M 0.18% 76
2025
Q3
$145M Sell
3,437,497
-117,570
-3% -$5.85M 0.23% 70
2025
Q2
$197M Buy
3,555,067
+1,301,571
+58% +$64.9M 0.32% 67
2025
Q1
$128M Buy
2,253,496
+30,957
+1% +$1.93M 0.21% 74
2024
Q4
$154M Sell
2,222,539
-15,045
-0.7% -$1.45M 0.2% 71
2024
Q3
$304M Buy
2,237,584
+278,414
+14% +$36.6M 0.4% 54
2024
Q2
$264M Buy
1,959,170
+144,751
+8% +$22.1M 0.45% 59
2024
Q1
$312M Sell
1,814,419
-97,453
-5% -$14.8M 0.5% 58
2023
Q4
$297M Buy
1,911,872
+37,407
+2% +$4.88M 0.51% 61
2023
Q3
$235M Buy
1,874,465
+78,646
+4% +$9.67M 0.46% 64
2023
Q2
$208M Buy
+1,795,819
New +$195M 0.39% 64

Other funds holding CE

Harris Associates's CE Position: Q1 2026 in Review

Harris Associates sold out of Celanese (CE) in Q1 2026, closing a stake of 3,401,656 shares — an estimated $144M sold.

Harris Associates first reported a position in CE in Q2 2023 and held it in 11 quarters. The position peaked at $312M in Q1 2024. 471 funds tracked by Wall St. Rank hold CE as of Q1 2026.

  • Harris Associates reported no remaining Celanese position as of Q1 2026 after selling out during the quarter.
  • Harris Associates sold 3,401,656 Celanese shares in Q1 2026, an estimated $144M.
  • Harris Associates first reported a position in Celanese in Q2 2023 and held it in 11 quarters.
  • Harris Associates's Celanese position peaked at $312M in Q1 2024.
  • 471 funds tracked by Wall St. Rank held Celanese as of Q1 2026.

Based on Harris Associates's 13F filing for Q1 2026, filed 15 May 2026.